3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
4
Prostatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurocognitive Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
pembrolizumab
16
Bevacizumab
11
Carboplatin
10
Nivolumab
8
Pemetrexed
7
Temozolomide
6
atezolizumab
5
Standard of Care
5
Prednisone
5
Exercise
5
Cyclophosphamide
5
Cetuximab
5
durvalumab
4
abemaciclib
4
Paclitaxel
4
Dexamethasone
4
Cisplatin
4
Blood Specimen Collection
4
dostarlimab
3
daratumumab
3
cabozantinib
3
Rituximab
3
Oxaliplatin
3
Metformin
3
Leucovorin
3
Lenalidomide
3
Ipilimumab
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Observation
×
30 days
×
Clear all
No trials found.